Promethera Biosciences Completes 39.7 Million ($44.4 Million) Series D Financing
MONT-SAINT-GUIBERT, Belgium & TOKYO--(BUSINESS WIRE)--May 7, 2019--Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, today announced the clo…
